| Autor: |
Ambica, Baru, Swati, Sharma, Biswa Pratim Das, Purakayastha, Sameena, Khan, Saumyabrata, Mazumdar, Reeshu, Gupta, Prabuddha K, Kundu, Nupur Mehrotra, Arora |
| Rok vydání: |
2021 |
| Předmět: |
|
| Zdroj: |
Assay and drug development technologies. 19(6) |
| ISSN: |
1557-8127 |
| Popis: |
The latest advancements in oncology are majorly focused on immuno-oncology (I-O) therapies. However, only ∼7% of drugs are being approved from the preclinical discovery phase to phase 1. The most challenging issues in I-O are the development of active and efficient drugs in an economically feasible way and in a comparatively short time for testing and validation. This mandates an urgent need for the upgradation of preclinical screening models that closely mimic the |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
